-
Your selected country is
Europe
- Change country/language
Old Browser
This page has been recently translated and is available in French now.
CLL Phenotyping with BD Rhapsody™ Targeted Panels and BD® AbSeq Assays
Chronic Lymphoid Leukemia (CLL), the most common form of leukemia in adults, is often characterised by progressive accumulation of incompetent lymphocytes in blood and bone marrow.
Computational Sorting With HyperFinder, FlowJo™ Software and BD FACSDiva™ Software
The use of machine learning tools like tSNE, UMAP, CITRUS and CellCNN for the analysis of flow cytometry data may result in the discovery of novel cell types with a distinct pattern of surface markers.
Intracellular Flow Cytometry Analysis Reveals the Involvement of Prostaglandin in the Expansion of Regulatory Hematopoietic Cells in Type 1 Diabetes
The transplant of Haematopoetic Stem and Progenitor cells (HSPC) has been employed in the treatment of haematological malignancies. However, studies have shown that HSPCs also possess immunoregulatory properties, making them potentially attractive alternatives to immunosuppressive drugs for the treatment of autoimmune diseases.
Analysing Pediatric Immune Response to SARS-CoV -2 Using Flow Cytometry
The COVID-19 pandemic has impacted every country in the world. In adults, 10-20% of the patients develop severe or life-threatening disease. However, in children, most patients display only minor symptoms and so their contributions to spreading the SARS-CoV-2 virus is unclear.
BD Joins Consortium to Accelerate Technology Development and Lower the Costs in Cell and Gene Therapy Manufacturing
Wouldn’t it be wonderful if we could reach a point in medical history where disease can be cured without drugs?
AbSeq Protocol Using the Nano-Well Cartridge-Based Rhapsody Platform to Generate Protein and Transcript Expression Data on the Single-Cell Level
The BD™ AbSeq oligonucleotide-conjugated antibodies, when incorporated into a single-cell mRNA-sequencing experiment, can yield combined transcript and protein expression data.
Bifidobacteria-Mediated Immune System Imprinting Early In Life
There is mounting evidence to suggest that during the first 3 months of life, the infant gut microbiome is crucial for immune development. Specialised microbes in the infant gut that rely on breast milk for nutrients play a key role in immune-microbe interactions.
Single-Cell Genomic Approaches for Developing the Next Generation of Immunotherapies
In recent times, developments in genomics, proteomics and single-cell technologies, coupled with advances in allied areas like computing and antibody engineering have enabled significant progress in drug development.
High-Dimensional Flow Cytometry in COVID-19
The rapid spread of COVID-19 infections all over the world and the need to develop a vaccine has necessitated the understanding of the adaptive immune response to the SARS-CoV-2 virus.
High-Parameter Flow Cytometry for Deep Immune Profiling of COVID-19 Patients
The SARS-CoV-2 virus infection presents a range of clinical manifestations, ranging from mild or no symptoms to moderate to severe respiratory illnesses, such as ARDS (acute respiratory-distress syndrome) and multiorgan failure, to death. The innate immune defense mounted by the body involves pattern recognition receptors (PAR), which activate an array of transcription factors through a signal transduction pathway, ultimately resulting in the secretion of different interferons and chemokines.
Immunotyping of Natural Killer (NK) Cells in COVID-19 Patients Using High-Parameter Flow Cytometry
SARS-CoV-2 infection elicits a spectrum of immune responses, activating both the innate and adaptive immune systems. Whether these immune responses are targeted and controlled or misdirected and uncontrolled could determine the outcome of the disease. Recent studies using deep immunoprofiling have indicated that the nature of immune responses can also determine the severity of the disease.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.